SUMMARY
This use of opioids with small doses of local anaesthetics increases the quality and duration of analgesia and decreases the total amount of bupivacaine required [3, 4] .
However, side effects such as nausea, pruritus and sedation still occur and, although the degree of motor block may be decreased, frequently it is still present at the last stage of labour.
Clonidine may be a useful adjuvant [5] : it produces analgesia via a non-opioid mechanism; unlike extradurally administered local anaesthetics, it does not interfere with proprioception and, unlike extradural opioids, it does not produce respiratory depression [6] , nausea or pruritus. It enhances the analgesic potency of opioids and local anaesthetics without increasing the incidence of side effects [7] .
The aim of our study was to see if the addition of a small dose of clonidine to a mixture of bupivacaine, sufentanil and adrenaline improved the duration of analgesia, reduced the number of injections or the total bupivacaine requirement and caused side effects in mother (motor block, pruritus, nausea, sedation) or child.
PATIENTS AND METHODS
The study was approved by the Hospital Ethics Committee. After obtaining informed consent, we studied 50 women, ASA I or II, who were candidates for extradural analgesia for labour. Complicated pregnancies were excluded. Parity was not a selection criteria. The parturients were allocated randomly to two equal groups. An extradural catheter was inserted at either the L2-3 or L3-4 lumbar intervertebral space.
After a test dose of 2 % lignocaine 2 ml with adrenaline 10 |ig, an initial volume of 10 ml containing one of the following drug combinations was injected in a double-blind fashion (patients, anaesthetists, obstetricians and neonatologists were blinded to solutions): Group A: bupivacaine 12.5 mg + adrenaline 25 ug + sufentanil 10 (ig.
Extradural analgesia for labour frequently comprises local anaesthetics in small concentrations (0.125% bupivacaine, or less) [1] , with or without adrenaline and highly lipid-soluble opioids such as fentanyl [2] or sufentanil [3] . Correspondence to B. LE P.
Group B: bupivacaine 12.5 mg + adrenaline 25 ug + sufentanil 10 ug + clonidine 30 )ig. Five millilitre of the solution was injected with the patient on her left side and 5 ml, 10 min later, with the patient on the right side.
The patients were permitted a second injection of the same solution for any pain.
Subsequently, patients in both groups received further 10-ml injections of bupivacaine 12.5 mg + adrenaline 25 ug, without sufentanil or clonidine. For the entire first stage of labour, the mother lay on one side except for obstetric examinations, when she was in the supine position with left lateral tilt.
At full dilatation as judged by the obstetrician, perineal sensory block was tested by use of an ether swab to assess loss of temperature sensation (corresponding to A5 and C fibre block) [8] . If anaesthesia was judged unsatisfactory, 10 ml of 0.125% bupivacaine with adrenaline 25 ug was injected in group A. The same mixture with clonidine 30 ug was given in group B with the patient in the sitting position.
We recorded the time when the injections were given, the duration of labour (first injection to delivery time) and the duration of analgesia provided by the first injection (interval between the first and the second injection).
Patient's evaluation of the efficacy of analgesia was reported on a verbal scale: very good (no or short periods of light pain); good (longer periods of pain, but still not disturbing); insufficient (permanent pain, dissatisfaction).
The evaluation of analgesia was repeated 30 min after each injection, at delivery and at the suture of episiotomy.
Haemodynamic monitoring of the mothers included non-invasive arterial pressure and heart rate, recorded every 5 min for 30 min after injections and every 15 min afterwards (Dinamap-Critikon, 1846 SX).
The degree of motor block was assessed on the Bromage scale: none, partial, almost complete, complete [9] .
The frequency of all side effects including nausea, pruritus, sedation and urinary retention was recorded, and the mode of delivery (spontaneous, forceps or Caesarean section).
The fetus was monitored during labour by continuous tocometry (baseline fetal heart rate, variability, decelerations) (Hewlett-Packard 8040 A).
The Apgar scores of the newborns were noted by a neonatologist at 1, 5 and 10 min. The babies were assessed again 1 and 2 days after birth (general examination and Dubowitz score).
On the day after delivery, another anaesthetist questioned the mothers about their general evaluation of the pain relief during each stage of labour and episiotomy, their participation during expulsion (perception of the contractions, strength to push) and any side effects experienced during and after labour; they were discharged on day 6 after a general examination.
Means of independent variables were analysed by analysis of variance. Categorical variables were cross-BRITISH JOURNAL OF ANAESTHESIA tabulated. The statistical significance of relationships between cross-tabulated variables was based on Spearman R statistic. P < 0.05 was considered statistically significant.
RESULTS
Patients in the two groups were comparable in characteristics and labour variables (table I) .
There was no difference in analgesia between the two groups, with a high incidence of very good pain relief in both groups: 23 of 25 patients in group A and 24 of 25 in group B for the two stages of labour; two patients in group A and one patient in group B had good analgesia for the first stage of labour; for the second stage, one in both groups had good pain relief and one in group A had insufficient pain relief.
Twenty-four patients in group A and 22 patients in group B required a last injection because of unsatisfactory perineal analgesia as assessed by cold swab.
Despite this supplementary perineal injection, five of 20 patients in group A found suture of episiotomy painful; all 21 group B mothers who underwent episiotomy were totally satisfied (table II) .
The duration of labour, the number of injections and the total bupivacaine requirements did not differ between groups, but there was a slight decrease in hourly consumption of bupivacaine in group B.
The duration of analgesia after the first injection, in women who had received at least two injections during the first stage of labour, was not significantly modified by clonidine: 142 min in group A and 127 min in group B (table III) .
The frequency of side effects was comparable in the two groups (table IV) . Hypotension (decrease of more than 20% of the values before extradural injection) was treated first by fluids (four patients in each group) then, if persistent despite 500-1000 ml of fluids, by ephedrine 5-10 mg (one patient in each group). The degree of motor block did not differ between groups and the participation of the mother during the expulsion stage was excellent in 80 % of the mothers; however, three deliveries required instrumental assistance (forceps) in group B (table  V) .
Two children (one in each group) presented with an Apgar score less than 8 at 1 min, but all the children recovered to an Apgar score greater than 8 at 5 and 10 min. There were no problems in the 24 h after birth.
DISCUSSION
Clonidine is a highly lipid soluble alpha 2 adrenergic agonist which acts via a non-opioid mechanism involving alpha 2 receptors at the dorsal horn [10] [11] [12] [13] .
When it is used alone, large doses are necessary to obtain pain relief, with hypotension and sedation in consequence [14] [15] . However, combination with other drugs acting on different sites of the pain transmission pathways allows the dose of each component to be decreased: clonidine alone prolongs the sensory block of local anaesthetics and has a synergistic effect with extradural opioids [16] [17] [18] [19] . When it is combined with another adrenergic agonist such as adrenaline, this prolonging effect on the spinal block of local anaesthetics is more marked. This effect does not depend on a local vasoconstriction, but is most probably produced by action on the descending adrenergic inhibitory system [20, 21] .
During pregnancy, systemic clonidine is safe: doses in the range 150-900 ug have been shown to be safe for the treatment of pregnancy-induced hypertension [22] . It produces contractions of the human myometrium and uterine arteries in vitro, but does not increase the incidence of premature labour or the frequency of uterine contractions in vivo; it crosses the placental barrier easily, but no side effects have been described on the newborn during the neonatal period [23] [24] [25] [26] .
Extradural clonidine during pregnancy has been studied in a sheep model; a minor decrease in heart rate in ewes and fetus was noted, without changes in maternal and fetal blood pressure, intrauterine pressure or uterine blood flow [5] .
For this first double-blind study, we chose a control solution known to be effective and used routinely in our institution (bupivacaine 12.5 mg with adrenaline and sufentanil 10 ug) [4, 27] , to which a small dose of clonidine (3 x 30 ug maximum) was added. The bolus injection was preferred because it is used commonly in our unit, and the dose of clonidine 30 ug was chosen in accordance with our previous study [28] .
Our experience confirmed the efficacy of the solution of 0.125% bupivacaine with adrenaline 25 ug and sufentanil 10 ug with 92% (23 of 25) of patients having very good analgesia during the two stages of labour.
We preferred to limit the total dose of clonidine to 90 ug to avoid possible side effects caused by cumulative doses of extradural clonidine. After the first two injections, no more clonidine was added to the solution. However, few patients would have been candidates for more than two injections: three in group A (one with three injections; two with four injections) and four in group B (one with three injections; three with four injections).
The addition of clonidine 30 ug did not improve the quality or the duration of analgesia; it did not decrease the number of injections for the first stage of labour; it produced a slight decrease in hourly bupivacaine requirement, which was statistically significant but must be interpreted with care because of the large variations between the two groups. This small difference has little clinical significance.
This apparent lack of benefit may be explained by several factors: the small dose of clonidine used in comparison with the relative large doses of bupivacaine and sufentanil and the pharmacokinetic properties of the two adjuvants, clonidine and sufentanil. Both clonidine and sufentanil are lipid soluble; they disappear quickly from the site of injection and diffuse into CSF and plasma. After a single extradural injection, the CSF concentration of clonidine increases to a maximum after 60 min and declines quickly with an elimination half-life of 1 h [29] . For sufentanil, the peak concentration appears earlier (within 30 min) and the elimination half-life is much longer (160 min) [30] .
The quicker and longer action of an effective dose of sufentanil, such as 10 ug, could probably mask the effect of clonidine when injected at the same time in bolus injection. Continuous infusions of the same total hourly doses of clonidine and sufentanil should perhaps produce more constant analgesia and a greater decrease in bupivacaine requirements.
Analgesia for episiotomy, however, was very good in 15 of 20 patients in group A, and in all the patients (21) in group B. The three instrumental deliveries in group B reflect the same overall percentage of instrumental deliveries in our institution (12%).
There were no problems in our neonates. This is not surprising, as systemic (oral or i.v.) doses of more than 300 ug of clonidine have been shown to be safe [19] .
In conclusion, within the limits of the present study, no side effects were seen with small doses of clonidine for obstetric analgesia in a group of 25 patients. Much larger numbers would be required to demonstrate the safety of the drug in wider application. The addition of small doses of clonidine in a bolus regimen of 30 ug with bupivacaine 12.5 mg with adrenaline and sufentanil 10 ug produced better analgesia for episiotomy, but this benefit appeared not to be of great clinical significance.
